Recent advancements, such as the nine-factor IHC classifier (including PD-L1, CD8+, and macrophage markers), have further refined prognostic stratification in early-stage HCC, augmenting traditional systems like BCLC staging [153]. This evidence concerns the gene CD8A and hepatocellular carcinoma.